Log In
Print
BCIQ
Print
Print this Print this
 

DPI-289

  Manage Alerts
Collapse Summary General Information
Company Eboo Pharmaceuticals Inc.
DescriptionDelta Agonist/Mu Antagonist (DAMA)
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor antagonist; Delta opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat levodopa-induced dyskinesia in patients with Parkinson's disease (PD); Treat Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today